{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:46:35Z","timestamp":1773272795548,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2 R01 ES010845"],"award-info":[{"award-number":["2 R01 ES010845"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011073","name":"Nutrition Obesity Research Center, University of North Carolina","doi-asserted-by":"publisher","award":["DK056350"],"award-info":[{"award-number":["DK056350"]}],"id":[{"id":"10.13039\/100011073","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.taap.2012.07.024","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T10:48:06Z","timestamp":1343731686000},"page":"121-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Methylation of arsenic by recombinant human wild-type arsenic (+ 3 oxidation state) methyltransferase and its methionine 287 threonine (M287T) polymorph: Role of glutathione"],"prefix":"10.1016","volume":"264","author":[{"given":"Lan","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jesse","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Drobn\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felecia S.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pencheng","family":"Xun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"St\u00fdblo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.07.024_bb0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.taap.2009.01.015","article-title":"Genetic polymorphisms in AS3MT and arsenic metabolism in residents of the Red River Delta, Vietnam","volume":"236","author":"Agusa","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.024_bb0010","first-page":"429","article-title":"Biological methylation","volume":"12","author":"Challenger","year":"1951","journal-title":"Adv. Enzymol."},{"key":"10.1016\/j.taap.2012.07.024_bb0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/toxsci\/kfr246","article-title":"Mouse arsenic (+3 oxidation state) methyltransferase genotype affects metabolism and tissue dosimetry of arsenicals after arsenite administration in drinking water","volume":"124","author":"Chen","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.07.024_bb0020","first-page":"1653","article-title":"Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer","volume":"20","author":"Chung","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.taap.2012.07.024_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0162-0134(84)85038-2","article-title":"The reduction of trimethylarsine oxide to trimethylarsine by thiols: a mechanistic model for the biological reduction of arsenicals","volume":"21","author":"Cullen","year":"1984","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.taap.2012.07.024_bb0030","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/taap.2001.9226","article-title":"Determination of trivalent methylated arsenicals in biological matrices","volume":"174","author":"Del Razo","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.024_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1476-069X-10-73","article-title":"Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimap\u00e1n and Lagunera Regions in Mexico","volume":"10","author":"Del Razo","year":"2011","journal-title":"Environ. Health"},{"key":"10.1016\/j.taap.2012.07.024_bb0040","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1039\/B407388F","article-title":"Comprehensive analysis of arsenic metabolites by pH-specific hydride generation atomic absorption spectrometry","volume":"19","author":"Devesa","year":"2004","journal-title":"J. Anal. At. Spectrom."},{"key":"10.1016\/j.taap.2012.07.024_bb0045","unstructured":"Drobn\u00e1, Z., Del Razo, L.M., Garc\u00eda-Vargas, G.G., Valenzuela, O.L., Hernandez-Castellanos, E., S\u00e1nchez-Pe\u00f1a, L.C., St\u00fdblo, M., Loomis, D., in press. AS3MT polymorphism and prevalence of diabetes among residents of the Zimapan and Lagunera regions in Mexico. J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.taap.2012.07.024_bb0050","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1289\/ehp.9734","article-title":"Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina","volume":"115","author":"Engstr\u00f6m","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2012.07.024_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1289\/ehp.1002471","article-title":"Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism","volume":"119","author":"Engstr\u00f6m","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2012.07.024_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.taap.2008.09.026","article-title":"Ethnic differences in five intronic polymorphisms associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene","volume":"234","author":"Fujihara","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.024_bb0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.coph.2007.06.003","article-title":"Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress","volume":"7","author":"Gallogly","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.024_bb0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00204-004-0620-x","article-title":"A new metabolic pathway of arsenite: arsenite\u2013glutathione complexes are substrates for human arsenic methyltransferase Cyt19","volume":"79","author":"Hayakawa","year":"2005","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2012.07.024_bb0075","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2217\/14622416.9.8.1113","article-title":"Genetic variations associated with interindividual sensitivity in the response to arsenic exposure","volume":"9","author":"Hern\u00e1ndez","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.taap.2012.07.024_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/FPC.0b013e3282f7f46b","article-title":"High arsenic metabolic efficiency in AS3MT287Thr allele carriers","volume":"18","author":"Hern\u00e1ndez","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.taap.2012.07.024_bb0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mrfmmm.2007.07.004","article-title":"Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile","volume":"637","author":"Hern\u00e1ndez","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2012.07.024_bb0090","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1039\/B706144G","article-title":"Speciation of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer)","volume":"23","author":"Hern\u00e1ndez-Zavala","year":"2008","journal-title":"J. Anal. At. Spectrom."},{"key":"10.1016\/j.taap.2012.07.024_bb0095","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.envres.2011.05.003","article-title":"Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes","volume":"111","author":"Hsieh","year":"2011","journal-title":"Environ. Res."},{"key":"10.1016\/j.taap.2012.07.024_bb0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.taap.2010.09.017","article-title":"Arsenic (+3 oxidation state) methyltransferase genotype affects steady-state distribution and clearance of arsenic in arsenate-treated mice","volume":"249","author":"Hughes","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.024_bb0105","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1039\/c000844c","article-title":"Genetic polymorphism of As3MT and delayed urinary DMA excretion after organic arsenic intake from oyster ingestion","volume":"12","author":"Hwang","year":"2010","journal-title":"J. Environ. Monit."},{"key":"10.1016\/j.taap.2012.07.024_bb0110","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1021\/tx9900775","article-title":"Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase","volume":"12","author":"Lin","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.07.024_bb0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/tx0001878","article-title":"Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes","volume":"14","author":"Lin","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.07.024_bb0120","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1074\/jbc.M110246200","article-title":"A novel S-adenosyl-L-methionine: arsenic(III) methyltransferase from rat liver cytosol","volume":"277","author":"Lin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.07.024_bb0125","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1289\/ehp.10026","article-title":"Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms","volume":"115","author":"Lindberg","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2012.07.024_bb0130","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1021\/bi201500c","article-title":"Identification of catalytic residues in the As(III) S-adenosylmethionine methyltransferase","volume":"51","author":"Marapakala","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.taap.2012.07.024_bb0135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.sab.2007.11.037","volume":"63","author":"Matou\u0161ek","year":"2008","journal-title":"Spetrochim. Acta Part B"},{"key":"10.1016\/j.taap.2012.07.024_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2006.07.002","article-title":"Arsenate reduction: thiol cascade chemistry with convergent evolution","volume":"362","author":"Messens","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.taap.2012.07.024_bb0220","doi-asserted-by":"crossref","first-page":"e1002522","DOI":"10.1371\/journal.pgen.1002522","article-title":"Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh","volume":"82","author":"Pierce","year":"2012","journal-title":"PLoS Genet."},{"issue":"8","key":"10.1016\/j.taap.2012.07.024_bb0150","doi-asserted-by":"crossref","first-page":"e1000461","DOI":"10.1371\/journal.pcbi.1000461","article-title":"How thioredoxin dissociates its mixed disulfide","volume":"5","author":"Roos","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.taap.2012.07.024_bb0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/toxsci\/kfq173","article-title":"Arsenic induces DNA damage in environmentally exposed Mexican children and adults. Influence of GSTO1 and AS3MT polymorphisms","volume":"117","author":"Sampayo-Reyes","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.07.024_bb0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cbi.2008.12.018","article-title":"Structure-function roles of four cysteine residues in the human arsenic (+3 oxidation state) methyltransferase (hAS3MT) by site-directed mutagenesis","volume":"179","author":"Song","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2012.07.024_bb0165","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.biochi.2010.07.002","article-title":"New insights into the mechanism of arsenite methylation with the recombinant human arsenic (+3) methyltransferase (hAS3MT)","volume":"92","author":"Song","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.taap.2012.07.024_bb0225","series-title":"Toxicology of Metals\u2014Biochemical Aspects","first-page":"407","article-title":"Biological mechanisms and toxicological consequences of the methylation of arsenic","volume":"vol. 115","author":"Styblo","year":"1995"},{"key":"10.1016\/j.taap.2012.07.024_bb0175","doi-asserted-by":"crossref","first-page":"24522","DOI":"10.1074\/jbc.274.35.24522","article-title":"Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases","volume":"274","author":"Sun","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.07.024_bb0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/taap.2001.9258","article-title":"The cellular metabolism and systemic toxicity of arsenic","volume":"176","author":"Thomas","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.024_bb0185","first-page":"3","article-title":"Arsenic (+3 oxidation state) methyltransferase and methylation of arsenicals","volume":"232","author":"Thomas","year":"2007","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.taap.2012.07.024_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/003685049908200104","article-title":"Methylation of inorganic arsenic in different mammalian species and population groups","volume":"82","author":"Vahter","year":"1999","journal-title":"Sci. Prog."},{"key":"10.1016\/j.taap.2012.07.024_bb0195","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1289\/ehp.7519","article-title":"Urinary trivalent methylated arsenic species in population chronically exposed to inorganic arsenic","volume":"113","author":"Valenzuela","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2012.07.024_bb0200","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.taap.2009.06.007","article-title":"Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions","volume":"239","author":"Valenzuela","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.024_bb0205","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/tx0342161","article-title":"Endogenous reductants support catalytic function of recombinant rat cyt19, an arsenic methyltransferase","volume":"17","author":"Waters","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.07.024_bb0210","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1021\/tx0497853","article-title":"Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine","volume":"17","author":"Waters","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.07.024_bb0215","doi-asserted-by":"crossref","first-page":"7364","DOI":"10.1074\/jbc.M512227200","article-title":"Human arsenic methyltransferase (AS3MT) pharmacogenetics. Gene resequencing and functional genomics studies","volume":"281","author":"Wood","year":"2006","journal-title":"J. Biol. Chem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12003250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12003250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:42:07Z","timestamp":1758573727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12003250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0041008X12003250"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.07.024","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylation of arsenic by recombinant human wild-type arsenic (+3 oxidation state) methyltransferase and its methionine 287 threonine (M287T) polymorph: Role of glutathione","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2012.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}